Blood DonationNCT04306055
Blood Donor Recruitment During Epidemic of COVID-19
A study testing Questionnaire with precaution information and Experimental: Questionnaire without precaution information in people with Blood Donation, run by Guangzhou Blood Center at 1 site in China.
Trial summary
In December 2019, an unknown pneumonia rapidly spread in Wuhan, China, a new coronavirus, 2019 novel coronavirus (2019-nCoV), aroused the attention of the entire world. On January 31, 2020, World Health Organization (WHO) announced the outbreak of Coronavirus Disease 2019 (COVID-19) in China as a Public Health… Read more about this study
- Who is it for?
- Ages 18 to 60 years
- Conditions the study is for
- Blood Donation
- What is being tested?
- Questionnaire with precaution information and Experimental: Questionnaire without precaution information
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 19,491 participants
- Where
- 1 siteChina
- Study dates
- 13 Mar 2020to 3 Apr 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Blood donors whose last donation were between 1 Feb to 31 March, 2019.
Who cannot join
- Blood donors whose blood test results were positive. Blood donors who were aged above 60. Blood donors whose cell phone number was obviously invalid.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Blood Donor Recruitment During Epidemic of COVID-19 in Guangzhou, China
In December 2019, an unknown pneumonia rapidly spread in Wuhan, China, a new coronavirus, 2019 novel coronavirus (2019-nCoV), aroused the attention of the entire world. On January 31, 2020, World Health Organization (WHO) announced the outbreak of Coronavirus Disease 2019 (COVID-19) in China as a Public Health Emergency of International Concern. The number of volunteer non-remunerated blood donors decreased because of quarantine, caring for relatives, and fear of exposure to COVID-19. Due to the blood shortage, patient blood management and cessation of elective surgery are contributing to decreased demand, but sepsis may increase requirements and significant reductions will not be possible in areas such as trauma, cancer patients, hereditary haemolytic anaemias and childbirth. Therefore, recruiting enough blood donors during the epidemic is vital for public health in China, and also worldwide. In order to assess the effects of a questionnaire on blood donor recruitment, the investigators designed two kinds of self-administered, standardized and structured questionnaires. In addition of the basic socio-demographic characteristics, one questionnaire includes the information of precautions of blood donation during epidemic, and the other dose not. The questionnaires were randomly sent to ever blood donors, and the same number of ever blood donors are coded as control.
Read the detailed description
In order to assess the effects of a questionnaire on blood donor recruitment, the investigators designed two kinds of self-administered, standardized and structured questionnaires. In addition of the basic socio-demographic characteristics, one questionnaire includes the information of precautions of blood donation during epidemic, and the other dose not.
Information of precautions of blood donation during epidemic included taking donor's temperature and enhancing hand disinfection before donation etc.
The questionnaires were randomly sent to ever blood donors, and at the same day, equal number of ever blood donors as the ones who filled the questionnaire are coded as control.
- Conditions
- Blood Donation
- Being tested
- Questionnaire with precaution information, Experimental: Questionnaire without precaution information
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Questionnaire with precaution informationOther
Ever blood donors in this group would receive a questionnaire which includes some information about how donors can donate safely and how blood center will protect the blood donors during the epidemic of COVID-19.
Experimental: Questionnaire without precaution informationOther
Ever blood donors in this group would receive a questionnaire which dose not include the information above.
| Study group | Role | What they receive |
|---|---|---|
| Questionnaire with precaution information | Experimental | Questionnaire in this group includes information about precaution of blood donation during epidemic of COVID-19. Receives: Other: Questionnaire with precaution information |
| Questionnaire without precaution information | Experimental | Questionnaire in this group dose not include information about precaution of blood donation during epidemic of COVID-19. Receives: Other: Experimental: Questionnaire without precaution information |
| No questionnaire group | No intervention | Ever donors in this group would not receive the questionnaire. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Differences of attitude about blood donation towards different questionnaires
Compare participants' intention of blood donation after they read different information in the questionnaire.
Measured: 1 day
Secondary outcomes (1)
Rates of blood donation during 3 weeks
Blood donation rate of 3 groups will be followed
Measured: 3 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Mar 2020
- Study start13 Mar 2020
- Primary completion13 Mar 2020
- Study completion3 Apr 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Blood DonationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 19,491 participants (actual)
Sponsor and investigators
- Lead sponsor
- Guangzhou Blood Center
- Sponsor type
- Other government
- Responsible party
- Principal investigator, OUYANG Jian, Guangzhou Blood Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04306055
- Sponsor's protocol ID
- Blood donor recruitment
- Status last verified
- Apr 2020
- First submitted
- 8 Mar 2020
- Last updated
- 13 Apr 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Apr 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Blood Donor Recruitment During Epidemic of COVID-19 in Guangzhou, China
- ClinicalTrials.gov ID
- NCT04306055
- Acronym / sponsor ID
- Blood donor recruitment
- Conditions
- Blood Donation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 19,491 participants (actual)
- Lead sponsor
- Guangzhou Blood CenterOther government
- Study start
- 13 Mar 2020 (actual)
- Primary completion
- 13 Mar 2020 (actual)
- Study completion
- 3 Apr 2020 (actual)
- First posted
- 12 Mar 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In December 2019, an unknown pneumonia rapidly spread in Wuhan, China, a new coronavirus, 2019 novel coronavirus (2019-nCoV), aroused the attention of the entire world. On January 31, 2020, World Health Organization (WHO) announced the outbreak of Coronavirus Disease 2019 (COVID-19) in China as a Public Health Emergency of International Concern. The number of volunteer non-remunerated blood donors decreased because of quarantine, caring for relatives, and fear of exposure to COVID-19. Due to the blood shortage, patient blood management and cessation of elective surgery are contributing to decreased demand, but sepsis may increase requirements and significant reductions will not be possible in areas such as trauma, cancer patients, hereditary haemolytic anaemias and childbirth. Therefore, recruiting enough blood donors during the epidemic is vital for public health in China, and also worldwide. In order to assess the effects of a questionnaire on blood donor recruitment, the investigators designed two kinds of self-administered, standardized and structured questionnaires. In addition of the basic socio-demographic characteristics, one questionnaire includes the information of precautions of blood donation during epidemic, and the other dose not. The questionnaires were randomly sent to ever blood donors, and the same number of ever blood donors are coded as control.
Detailed description
In order to assess the effects of a questionnaire on blood donor recruitment, the investigators designed two kinds of self-administered, standardized and structured questionnaires. In addition of the basic socio-demographic characteristics, one questionnaire includes the information of precautions of blood donation during epidemic, and the other dose not.
Information of precautions of blood donation during epidemic included taking donor's temperature and enhancing hand disinfection before donation etc.
The questionnaires were randomly sent to ever blood donors, and at the same day, equal number of ever blood donors as the ones who filled the questionnaire are coded as control.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Questionnaire with precaution information | Experimental | Other: Questionnaire with precaution informationQuestionnaire in this group includes information about precaution of blood donation during epidemic of COVID-19. |
| Questionnaire without precaution information | Experimental | Other: Experimental: Questionnaire without precaution informationQuestionnaire in this group dose not include information about precaution of blood donation during epidemic of COVID-19. |
| No questionnaire group | No intervention | –Ever donors in this group would not receive the questionnaire. |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- Blood donors whose last donation were between 1 Feb to 31 March, 2019.
Key exclusion criteria (1 listed)
- Blood donors whose blood test results were positive. Blood donors who were aged above 60. Blood donors whose cell phone number was obviously invalid.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Questionnaire with precaution informationEver blood donors in this group would receive a questionnaire which includes some information about how donors can donate safely and how blood center will protect the blood donors during the epidemic of COVID-19. | Other | Questionnaire with precaution information |
| Experimental: Questionnaire without precaution informationEver blood donors in this group would receive a questionnaire which dose not include the information above. | Other | Questionnaire without precaution information |
Primary outcome
Differences of attitude about blood donation towards different questionnaires
Time frame: 1 day
Compare participants' intention of blood donation after they read different information in the questionnaire.
1 secondary outcome
Rates of blood donation during 3 weeks
Time frame: 3 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Apr 2020.
- Individual participant dataSharing planned: No
Related trials for Blood Donation
Not yet recruiting
Cookies for Platelets
Blood Donation
Not yet recruitingObservational study
Donor Lifestyle and Nutritional Status, Blood Component Quality, and Patient Safety (ESENCIA)
Blood Donation, Blood Transfusion
Recruiting
grouP O wholE blooD : storagE leSion impacT And infLammation
Blood Donation, Blood Platelets
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Questionnaire with precaution information and Experimental: Questionnaire without precaution information in people with Blood Donation, run by Guangzhou Blood Center at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Apr 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Differences of attitude about blood donation towards different questionnaires (time frame: 1 day). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2020.